Abstract
hCAP-18 is a newly described protein of human neutrophilic granulocytes which belongs to the cathelicidin family of antimicrobial proteins. Members of this protein family share a common N-terminal sequence followed by a highly diverse antimicrobial, cationic C-terminus. The present work describes the production of recombinant hCAP-18, the generation of antibodies to the protein and the development of an accurate, sensitive and specific ELISA for the detection of hCAP-18 in cells, plasma and urine with a detection limit of 0.084 ng/ml. The amount of hCAP-18 in neutrophils is 0.627 microgram protein per 10(6) cells. The plasma level is 1.18 micrograms/ml which is several fold higher than for other neutrophil specific granule proteins. hCAP-18 is present in plasma as high molecular weight complexes. In accordance with this, hCAP-18 is barely excreted in the urine. The bone marrow appears to be the major source of plasma hCAP-18. The high level of hCAP-18 in plasma may provide an important defense against microorganisms and endotoxins.
Original language | English |
---|---|
Pages (from-to) | 53-59 |
Number of pages | 7 |
Journal | Journal of Immunological Methods |
Volume | 206 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 1997 Aug 7 |
Externally published | Yes |
Subject classification (UKÄ)
- Immunology in the Medical Area (including Cell and Immunotherapy)
Free keywords
- Animals
- Anti-Infective Agents/blood
- Antibodies/chemistry
- Antimicrobial Cationic Peptides
- Carrier Proteins/blood
- Cathelicidins
- Enzyme-Linked Immunosorbent Assay/methods
- Humans
- Neutrophils/chemistry
- Plasma/chemistry
- Rabbits
- Reproducibility of Results
- Sensitivity and Specificity